Wainer Andrea F's Form 4 filing
Abbott Laboratories (ABT) · filed Dec 18, 2023
- Accession no.
- 0001415889-23-016642
- Filed
- Dec 18, 2023
- Trade date
- Dec 14, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.62M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wainer Andrea FCIK 0001778070 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common shares without par value | MOption exerciseAcquired | +15,000 | $44.40 | +$666,000 | 80,027 | Direct | |
| Dec 14, 2023 | Common shares without par value | SSaleDisposed | −15,000 | $108.00 | −$1,620,000 | 65,027 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Common Shares | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 38,271 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.